Abstract
Intratumoral G100 Induces Systemic Immunity and Abscopal Tumor Regression in Patients with Follicular Lymphoma: Results of a Phase 1/ 2 Study Examining G100 Alone and in Combination with Pembrolizumab
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have